Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on August 10, 2021. The registrant is incorporated in Delaware and maintains its principal executive offices in Nashville, Tennessee. The company's common stock and 8.625% Senior Notes due 2026 trade on The NASDAQ Global Market under the symbols HROW and HROWL, respectively.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure of a corporate presentation rather than a financial statement update.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is limited to the disclosure of a corporate presentation used by management at investor conferences.
Guidance, Outlook, and Risks
Item 7.01 discloses the attachment of a corporate presentation (Exhibit 99.1) dated August 2021. The filing explicitly states that the information contained in this presentation is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated. Consequently, specific guidance, outlook, or risk factors detailed in the presentation are not available within the text of this 8-K.
Key Facts for Investor Verification
- The filing is a Regulation FD disclosure referencing an attached corporate presentation (Exhibit 99.1) rather than a standalone financial update.
- Information in the attached presentation is not legally "filed" or incorporated by reference in this document.
- Investors must review Exhibit 99.1 directly to access any management commentary, strategic outlook, or financial projections.
- The report confirms the company's status as a registrant with securities listed on The NASDAQ Global Market.